Actively Recruiting

Phase 3
Age: 18Years - 70Years
FEMALE
NCT05969457

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach

Led by University Hospital, Rouen · Updated on 2026-05-12

108

Participants Needed

2

Research Sites

206 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Rouen

Lead Sponsor

G

Groupe Hospitalier du Havre

Collaborating Sponsor

AI-Summary

What this Trial Is About

The research procedure is the injection of 20 mL of Ropivacaine solution (vs. saline) to create a paracervical block at the beginning of surgery, while the patient is already under general anesthesia. This injection will take place 3 minutes before the vaginal incision, via 4 injection points. Injections are made 3 mm deep into the vaginal cul de sac. Randomization takes place before surgery by vNOTES: * Experienced group: Local anesthesia with injection of Ropivacaine (20mL of ropivacaine 7.5 mg/mL, i.e. 150mg) and general anesthesia * Control group: Injection of 20mL of placebo (saline) and general anesthesia In both groups, systematic intraoperative and postoperative analgesia will be identical.

CONDITIONS

Official Title

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach

Who Can Participate

Age: 18Years - 70Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 to 70 inclusive
  • Scheduled for vNOTES surgery for total hysterectomy for benign pathology, with or without adnexal procedure
  • Have read and understood the information letter and signed the consent form
  • Affiliated with a social security scheme
Not Eligible

You will not qualify if you...

  • Suspicion of malignant pathology
  • History of rectal surgery
  • History of pelvic inflammatory disease
  • Suspicion of recto-vaginal endometriosis
  • Virginity
  • Contraindication to Ropivacaine 7.5 mg/mL solution for injection
  • Contraindication to sodium chloride 0.9% solution for injection
  • On a low-salt diet
  • History of more than 2 cesarean sections
  • Estimated uterine size greater than 700 g based on preoperative imaging
  • BMI greater than 35
  • Contraindication to analgesic molecules used in intraoperative and postoperative protocols

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Gh Le Havre

Le Havre, France, 76083

Actively Recruiting

2

Chu Rouen

Rouen, France, 76031

Actively Recruiting

Loading map...

Research Team

P

Patrice Crochet, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here